Health Care: Drugs

Durata Therapeutics Inc (DRTX: NASDAQ)

$15.76 0.24 | 1.55%
08/29/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011
Sales 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00
Selling, General, and Administrative Expenses 18.60M 9.79M 4.31M
Research & Development 37.32M 51.69M 30.13M
Operating Income before D & A (EBITDA) -55.92M -61.48M -34.44M
Depreciation & Amortization 253.00K 14.60K 0.00
Interest Income 62.00K 40.85K 15.36K
Other Income - Net -2.78M 0.00 0.00
Special Income / Charges 1.05M 0.00 0.00
Total Income Before Interest Expenses (EBIT) -58.89M -62.55M -35.54M
Interest Expense 2.23M 0.00 0.00
Pre-Tax Income -61.12M -62.55M -35.54M
Income Taxes 1.28M 0.00 -2.51M
Minority Interest 0.00 0.00 0.00
Net Income From Continuing Operations -62.14M -62.54M -33.03M
Net Income From Discontinued Operations 0.00 0.00 0.00
Net Income From Total Operations -62.14M -62.54M -33.03M
Extraordinary Income/Losses 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00
Total Net Income -62.14M -62.54M -33.03M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-62.14M -61.44M -31.91M
Preferred Dividends
Net Income Available To Common -62.14M -62.54M -33.03M
Basic EPS from Continuing Ops. -2.57 -7.48 -3.40
Basic EPS from Discontinued Ops. 0.00 0.00 0.00
Basic EPS from Total Operations -2.57 -7.48 -3.40
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00
Basic EPS, Total -2.57 -7.48 -3.40
Basic Normalized Net Income/Share -2.57 -7.35 -3.29
EPS fr Continuing Ops. -2.57 -7.48 -3.40
EPS fr Discontinued Ops 0.00 0.00 0.00
EPS fr Total Ops. -2.57 -7.48 -3.40
EPS fr Extraord. Inc. 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00
EPS, Total -2.57 -7.48 -3.40
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.57 -7.35 -3.29
Dividends Paid per Share 0.00 0.00 0.00

Portfolios with DRTX

Latest DRTX Headlines from TheStreet

More Financial News for DRTX

Press Releases for DRTX

See All Press Releases

Partner Headlines for DRTX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter